- Home
- PRPL vs GNLX Comparison
PRPL vs GNLX Comparison
Compare PRPL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- GNLX
- Stock Information
- Founded
- PRPL 2010
- GNLX 2001
- Country
- PRPL United States
- GNLX United States
- Employees
- PRPL N/A
- GNLX N/A
- Industry
- PRPL Home Furnishings
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- GNLX Health Care
- Exchange
- PRPL Nasdaq
- GNLX Nasdaq
- Market Cap
- PRPL 78.9M
- GNLX 112.5M
- IPO Year
- PRPL N/A
- GNLX 2023
- Fundamental
- Price
- PRPL $0.73
- GNLX $3.44
- Analyst Decision
- PRPL Hold
- GNLX Strong Buy
- Analyst Count
- PRPL 2
- GNLX 4
- Target Price
- PRPL $1.25
- GNLX $17.75
- AVG Volume (30 Days)
- PRPL 712.5K
- GNLX 153.5K
- Earning Date
- PRPL 08-04-2025
- GNLX 08-13-2025
- Dividend Yield
- PRPL N/A
- GNLX N/A
- EPS Growth
- PRPL N/A
- GNLX N/A
- EPS
- PRPL N/A
- GNLX N/A
- Revenue
- PRPL $472,015,000.00
- GNLX N/A
- Revenue This Year
- PRPL N/A
- GNLX N/A
- Revenue Next Year
- PRPL $10.65
- GNLX N/A
- P/E Ratio
- PRPL N/A
- GNLX N/A
- Revenue Growth
- PRPL N/A
- GNLX N/A
- 52 Week Low
- PRPL $0.56
- GNLX $1.60
- 52 Week High
- PRPL $1.50
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- PRPL 46.90
- GNLX 65.71
- Support Level
- PRPL $0.70
- GNLX $2.80
- Resistance Level
- PRPL $0.74
- GNLX $3.61
- Average True Range (ATR)
- PRPL 0.05
- GNLX 0.22
- MACD
- PRPL -0.00
- GNLX 0.05
- Stochastic Oscillator
- PRPL 25.46
- GNLX 80.23
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.